Form 4 for BCPC BALCHEM CORP
Accepted 2025-12-05 00:00:00 ET · period of report 2025-12-03 · accession 0001140361-25-044554 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-05 | 2025-12-03 | BCPC | Fischer David B | Dir | S - Sale+OE | $153.97 | -8,000 | 9,989 | -44% | -$1.23M |
| DM | 2025-12-05 | 2025-12-03 | BCPC | Fischer David B | Dir | M - OptEx | $78.72 | +6,000 | 13.4K | +81% | +$472.3K |
| DM | 2025-12-05 | 2025-12-03 | BCPC | Fischer David B | Dir | M - OptEx | $0.00 | -6,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-03 | S | D | 2,000 | $154.15 | 7,989 | D | — | — | (F3) This transaction was executed in multiple sales ranging from $153.9045 to $154.3400 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. |
| 2 | Common | Common Stock | 2025-12-03 | M | A | 2,617 | $84.09 | 15,989 | D | — | — | (F1) Exercise of fully vested non-qualified stock options. |
| 3 | Common | Common Stock | 2025-12-03 | M | A | 3,383 | $74.57 | 13,372 | D | — | — | (F1) Exercise of fully vested non-qualified stock options. |
| 4 | Common | Common Stock | 2025-12-03 | S | D | 6,000 | $153.91 | 9,989 | D | — | — | (F2) This transaction was executed in multiple sales ranging from $153.5100 to $154.2400 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. |
| 5 | Derivative | Stock Options | 2025-12-03 | M | D | 2,617 | $0.00 | 0 | D | $84.09 · — to 2029-02-13 | 2,617 Common Stock | (F5) Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable. |
| 6 | Derivative | Stock Options | 2025-12-03 | M | D | 3,383 | $0.00 | 0 | D | $74.57 · — to 2028-02-15 | 3,383 Common Stock | (F4) Stock options that vested 20% on February 15, 2019, 40% on February 15, 2020, and 40% on February 15, 2021, and are exercisable. |